Bing Xiu | Hematology | Best Researcher Award

Published on by Global Academic Awards

Prof. Bing Xiu | Hematology | Best Researcher Award

Prof. Bing Xiu | Tongji University | China 

Prof. Bing Xiu is an esteemed Associate Chief Physician and Vice Professor at the Department of Hematology, Tongji Hospital, Tongji University, Shanghai, China. With over two decades of experience in hematology, she holds a Ph.D. in Internal Medicine and has undertaken advanced training at the Mayo Clinic, USA. Prof. Xiu is a certified specialist in internal medicine and hematology and serves as a Master’s supervisor. Her research focuses on lymphoma, T-cell exhaustion, immunotherapy, and CAR-T related cytokine release syndrome. She has led and contributed to several major national and international research projects, including those funded by the NSFC and NIH. Prof. Xiu has published extensively in high-impact journals like Blood Cancer Journal, Leukemia, and Clinical Cancer Research, and has presented at ASH and ASCO, earning abstract honors. She also co-edited a clinical dataset book on diffuse large B-cell lymphoma and is active in several national medical associations and academic committees.

Publication Profile

Scopus

Education Background

Prof. Bing Xiu has pursued her entire medical education at the prestigious Medical College of Tongji University in Shanghai, China, demonstrating a consistent commitment to academic excellence and specialization in internal medicine. She began her journey in medicine by earning her Bachelor of Medicine degree from Tongji University, where she laid the foundational knowledge in clinical sciences. Her passion for hematology and internal medicine led her to further academic pursuit, completing her Master of Medicine from the same institution. With an increasing focus on clinical research and advanced therapeutics, Prof. Xiu earned her Ph.D. in Internal Medicine from Tongji University, focusing on cutting-edge areas of hematologic malignancies. This continuous and progressive educational pathway has equipped her with deep theoretical knowledge and advanced research capabilities that have significantly influenced her medical and academic career.

Professional Experience

Prof. Bing Xiu has built a distinguished career in hematology through extensive clinical, academic, and international experience. She serves as the Associate Chief Physician in the Department of Hematology at Tongji Hospital, Tongji University, Shanghai, where she also holds the role of Master’s supervisor. Her international exposure includes prestigious appointments as a Research Fellow and Visiting Clinician at the Mayo Clinic, Rochester, USA. Prof. Xiu’s earlier roles at Tongji Hospital include her tenure as a Fellow and as a Resident, marking a steady progression in her professional responsibilities. This rich blend of domestic and international clinical research and patient care has shaped her into a leader in hematology and academic mentorship.

Professional Certifications

Prof. Bing Xiu holds esteemed certifications that underscore her clinical expertise and professional standing in the field of internal medicine and hematology. She is certified by the Chinese Board of Internal Medicine, which affirms her comprehensive proficiency in diagnosing and managing a wide range of medical conditions. In addition, she possesses a specialized certification in Internal Medicine-Hematology from the same board, highlighting her focused expertise in the diagnosis and treatment of blood disorders, hematologic malignancies, and related immunological conditions. These dual certifications not only reflect her advanced clinical training but also qualify her to deliver high-level patient care, contribute to academic leadership, and mentor postgraduate students in hematology. Recognized by national regulatory authorities, these credentials form the foundation of her credibility and professionalism in China’s medical and academic community, supporting her roles in major research projects, teaching, and leadership in national medical societies.

Research Focus

Prof. Bing Xiu focuses her research on the molecular and translational mechanisms underlying hematologic malignancies, with particular emphasis on lymphomas and myeloproliferative neoplasms. Her recent publications explore critical areas such as germline mutations in lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH), indicating an interest in immune dysregulation and genetic predisposition in aggressive B-cell lymphomas. She has also investigated epigenetic and genetic alterations, such as single nucleotide polymorphisms and promoter methylation of protein tyrosine phosphatase 1B, in myeloproliferative disorders, showcasing her engagement in cancer genomics. Furthermore, her research integrates cutting-edge immunotherapies, including CAR T-cell therapy combined with autologous hematopoietic cell transplantation for refractory/relapsed Burkitt lymphoma, indicating her commitment to improving outcomes through personalized and cellular therapies. Collectively, her work lies at the intersection of cancer genetics, immunotherapy, and translational hematology, making significant contributions to advancing targeted and immune-based treatments for hematologic cancers.

Publication Top Notes

1. Germline mutations in B-cell non-Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH) and patient outcomes
Publication Year: 2025

2. Single nucleotide polymorphism and promoter methylation analysis of protein tyrosine phosphatase 1B in patients with myeloproliferative neoplasms
Publication Year: 2025

3. CAR T-cell therapy combined with autologous hematopoietic cell transplantation in patients with refractory/relapsed Burkitt Lymphoma
Publication Year: 2025
Citations: 1

Conclusion

Prof. Bing Xiu is highly suitable for the Best Researcher Award. Her record combines clinical excellence, high-impact hematological research (particularly in lymphoma and immunotherapy), international collaboration, grant leadership, and academic publishing. With a few more translational innovations or expanded global leadership, she would stand at the pinnacle of international medical research. As it stands, she is a top-tier candidate whose body of work exemplifies the award’s purpose to honor groundbreaking research with societal and scientific relevance.

 

 

Romaric Tuono De Manfouo | Hematology | Best Research Article Award

Published on by Global Academic Awards

Mr. Romaric Tuono De Manfouo | Hematology | Best Research Article Award

Mr. Romaric Tuono De Manfouo, Université des Montagnes, Cameroon

Mr. Romaric Tuono De Manfouo is a dedicated Cameroonian biomedical researcher recognized for his contributions to hematology, infectious diseases, and public health. With a focus on sickle cell disease, hepatitis, and hematologic biomarkers, he has co-authored several peer-reviewed publications between 2019 and 2024. His research, often collaborative and cross-disciplinary, addresses critical health issues affecting vulnerable populations in Cameroon. Mr. Tuono De Manfouo has also served as a reviewer for reputable journals, showcasing his engagement with the broader scientific community. His scholarly output reflects a commitment to advancing diagnostic, therapeutic, and preventive approaches in low-resource settings. 🧬🌍📚

Publication Profile

Orcid

🎓 Education

Mr. Romaric Tuono De Manfouo pursued his academic training in biomedical sciences at the Higher Institute of Health Sciences, Université des Montagnes, Bangangté, West Cameroon. There, he specialized in clinical hematology, infectious diseases, and laboratory diagnostics, with an emphasis on tropical diseases and genetic disorders. His academic development was supported by rigorous coursework, clinical internships, and research mentorship. This foundation allowed him to explore the biochemical, immunologic, and epidemiological aspects of blood-related disorders, leading to impactful contributions in peer-reviewed journals. His academic background also includes training in research methodology and ethics, equipping him for multidisciplinary collaborations. 🏥📖🧪

💼 Experience

Mr. Tuono De Manfouo has contributed to both research and clinical diagnostics through academic affiliations with institutions in Cameroon. As a researcher, he co-authored multiple studies focused on sickle cell disease, hepatitis, and hematologic markers, published in international journals including the World Journal of Hematology and Biomedical Sciences. He has worked closely with clinicians, laboratorians, and public health experts on cross-sectional and serological studies. In addition, he served as a peer reviewer for journals such as Health Science Reports and Clinical Interventions in Aging. His collaborative roles underline his interdisciplinary expertise and scientific rigor. 🔬🧑‍⚕️📝

🏅 Awards and Honors

Although specific formal awards are not listed, Mr. Romaric Tuono De Manfouo’s recognition comes through his scholarly activity and peer-review contributions. His invitation to review articles in well-regarded journals and his involvement in multiple high-impact studies signify his growing academic stature. His 2024 article in the World Journal of Hematology and his research on thrombotic risk in sickle cell patients stand out as significant achievements. His work continues to be acknowledged by academic peers and institutions for its relevance to public health in Sub-Saharan Africa. He is a promising candidate for research-based honors and awards. 🏆📄🎖️

🔬 Research Focus

Mr. Tuono De Manfouo’s research centers on hematologic disorders, particularly sickle cell disease, iron metabolism, hemostasis, and infectious diseases like Hepatitis B. He investigates biomarkers such as haptoglobin, the genetic profile of G6PD deficiency, and the serological status of vulnerable populations. His studies aim to elucidate disease mechanisms, inform risk stratification, and enhance healthcare delivery in resource-limited settings. His preprints and published studies contribute to a better understanding of the inflammatory profile in pediatric patients and hematologic complications in chronic illnesses. His interdisciplinary approach bridges laboratory science, epidemiology, and clinical practice. 🧫🧪🩸🧠

Publication Top Notes

📌 Plasminogen as a Marker for Assessing Thrombotic Risk During Hepatitis in Cameroon (2025) | Health Science Reports | DOI: 10.1002/hsr2.70648

📌 Haptoglobin Gene Polymorphism and Iron Profile in SCD Patients with Inflammation in Yaoundé (2024) | Mol Genet Genomic Med | DOI: 10.1002/MGG3.2302

📌 Hematological and Hemostasis Profile, Thrombotic Risk in SCD in Cameroon (2024) | Hematology and Disorders | DOI: 10.58489/2836-3582/011 🩺

📌 Hyperuricemia and Associated Factors at Bafoussam Hospital (2024) | Health Science Reports | DOI: 10.1002/HSR2.1891

📌 Inflammation and Iron Profile in Children with SCD in Cameroon (2024) | Preprints.org | DOI: 10.20944/PREPRINTS202403.1721.V1 🩸

📌 Involvement of Haptoglobin in Disease Development (2024) | World Journal of Hematology | DOI: 10.5315/WJH.V11.I2.94171

📌 Prevalence of Anemia and Iron Deficiency Among Diabetics in West Cameroon (2024) | Preprint | DOI: 10.1101/2024.12.12.24318970 🩸

📌 Anti-Erythrocyte Alloimmunisation in RH System During CKD (2023) | Open Access Library Journal | DOI: 10.4236/OALIB.1109932

📌 G6PD Deficiency in Icteric Newborns in Yaoundé (2023) | Open Journal of Blood Diseases | DOI: 10.4236/OJBD.2023.131005

📌 Homozygote Drepanocytosis: Ferric Status and Inflammation – Review & Meta-Analysis (2023) | Health Science Reports | DOI: 10.1002/HSR2.1609

📌 Serological Status of Hepatitis B Virus Among Pregnant Women (Mifi, Cameroon) (2023) | Biomedical Sciences | DOI: 10.11648/J.BS.20230902.12

📌 Serological Status of HBV Among Sex Workers in Douala (2023) | Biomedical Sciences | DOI: 10.11648/J.BS.20230902.13

📌 Assessment of Vulnerability to COVID-19 in Central Africa (2022) | Disaster Med Public Health Prep | DOI: 10.1017/DMP.2022.121

Maria Agustina Perusini | Malignant Hematology Award | Best Researcher Award

Published on by Global Academic Awards

Dr. Maria Agustina Perusini | Malignant Hematology Award | Best Researcher Award

Dr. Maria Agustina Perusini, Princess Margaret Cancer Centre, Canada

Dr. Maria Agustina Perusini, MD 🩺, is a dedicated Clinical Research Fellow specializing in Leukemia and Myeloproliferative Neoplasms (MPN) at the Princess Margaret Cancer Centre, University of Toronto. With a background in Hematology and Internal Medicine from the University of Buenos Aires, Argentina 🇦🇷, she holds numerous certifications and awards in the field of Oncology. Dr. Perusini is recognized for her research on hematological disorders, particularly myelodysplastic syndromes (MDS) and acute lymphoblastic leukemia (ALL). She contributes actively to academic journals and has presented her findings at prestigious conferences worldwide 🌍.

 

Publication Profile

Scopus

Education

Dr. Maria Agustina Perusini, MD 🩺, has pursued an illustrious academic journey, culminating in a diverse array of post-doctoral degrees and a master’s in Clinical Epidemiology. With her foundation in Medicine from the esteemed Hospital Italiano Buenos Aires School of Medicine 🏥, she further specialized in Internal Medicine and Hematology at the University of Buenos Aires. Her thirst for knowledge led her to delve into the complexities of clinical epidemiology, focusing on Myelodysplastic Syndrome for her master’s thesis. Dr. Perusini’s dedication and commitment are evident in her successful completion of all coursework and requirements, showcasing her expertise in medical research and patient care.

Employment

Dr. Maria Agustina Perusini, MD 🩺, currently serves as a Clinical Research Fellow specializing in Leukemia and Myeloproliferative Neoplasms (MPN) at the prestigious Princess Margaret Cancer Centre, University of Toronto 🌟. In addition to providing active care in MPN and leukemia clinics, she undertakes crucial clinical and research responsibilities. Notably, Dr. Perusini holds the position of Chief Fellow in the Leukemia program, showcasing her leadership within the Division of Medical Oncology at the University of Toronto. Previously, she held roles including Junior Attending Physician and Hemato-Oncology Fellow Supervisor at the Hospital Italiano de Buenos Aires, Argentina 🇦🇷, demonstrating her extensive experience and commitment to healthcare.

 

Research Focus

Dr. Maria Agustina Perusini, MD 🩺, primarily focuses her research on hematological malignancies and their treatment outcomes. She has contributed significantly to studies investigating acute lymphoblastic leukemia (ALL), chronic myelomonocytic leukemia (CMML), myelodysplastic syndromes (MDS), and their prognostic factors. Her work spans various aspects of these diseases, including the efficacy of treatment protocols such as asparaginase therapy and hematopoietic stem cell transplantation. Through her research, Dr. Perusini aims to improve understanding and management strategies for hematologic disorders, ultimately striving to enhance patient outcomes and quality of life.

 

Publication Top Notes: